Icure Pharmaceutical Incorporation Working Capital to Net Assets Ratio
Icure Pharmaceutical Incorporation working capital to net assets ratio. Icure Pharmaceutical Incorporation (175250) has a Working Capital to Net Assets ratio of -42.1% as of June 2025. Working capital of ₩-20.39 Billion (current assets of ₩50.08 Billion minus current liabilities of ₩70.47 Billion) is measured against net assets of ₩48.39 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Icure Pharmaceutical Incorporation tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Icure Pharmaceutical Incorporation (2015–2024)
Working capital to net assets ratio of Icure Pharmaceutical Incorporation from 2015 to 2024. This chart shows how Icure Pharmaceutical Incorporation's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at -42.1%, reflecting working capital of ₩-20.39 Billion against net assets of ₩48.39 Billion KRW. See 175250 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Icure Pharmaceutical Incorporation Working Capital to Net Assets Ratio by Year (2015–2024)
Icure Pharmaceutical Incorporation working capital to net assets ratio by year from 2015 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Icure Pharmaceutical Incorporation from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 175250 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -15.7% | ₩-9.46 Billion | ₩60.26 Billion | ₩55.09 Billion | ₩64.56 Billion | ▲ +91.1 pp |
| 2023 | -106.8% | ₩-63.63 Billion | ₩59.59 Billion | ₩31.81 Billion | ₩95.44 Billion | ▼ -74.1 pp |
| 2022 | -32.6% | ₩-29.28 Billion | ₩89.67 Billion | ₩80.70 Billion | ₩109.98 Billion | ▼ -36.8 pp |
| 2021 | 4.2% | ₩3.98 Billion | ₩95.76 Billion | ₩58.80 Billion | ₩54.82 Billion | ▼ -4.4 pp |
| 2020 | 8.6% | ₩9.62 Billion | ₩112.15 Billion | ₩43.73 Billion | ₩34.11 Billion | ▼ -22.2 pp |
| 2019 | 30.8% | ₩30.03 Billion | ₩97.53 Billion | ₩66.82 Billion | ₩36.79 Billion | ▼ -27.5 pp |
| 2018 | 58.3% | ₩49.41 Billion | ₩84.69 Billion | ₩64.28 Billion | ₩14.87 Billion | ▲ +20.1 pp |
| 2017 | 38.3% | ₩6.69 Billion | ₩17.47 Billion | ₩19.46 Billion | ₩12.77 Billion | ▲ +41.3 pp |
| 2016 | -3.1% | ₩-519.20 Million | ₩16.94 Billion | ₩10.99 Billion | ₩11.51 Billion | ▼ -189.9 pp |
| 2015 | 186.8% | ₩11.14 Billion | ₩5.96 Billion | ₩18.96 Billion | ₩7.82 Billion | — |